Literature DB >> 24681052

Validation of TaqMan® SNP genotyping specificity for rs12979860 of IL-28B: modeling primer specificity in vitro.

Brad S Thomas1, Michael A Joyce2, Aviad Levin2, D Lorne J Tyrrell3.   

Abstract

Members of the type III interferon gene family arose by gene duplication events and have retained a high percent identity both in their coding and non-coding regions. In this study, the specificity of a widely used TaqMan(®) SNP genotyping assay for rs12979860 is validated. The 66 bp template for SNP genotyping has only 3 bp at one 5' end that vary between IL-28B and IL-28A; excluding the rs12979860 SNP itself. Conflicting annealing temperatures were found for the mismatched 19 bp primer to IL-28B and IL-28A with in silico melting temperature algorithms, or with in vitro dissociation curves. In order to prove specificity for IL-28B, an in vitro competition assay was setup with genomic DNA and synthetic oligonucleotides. When genomic DNA, containing equimolar concentrations of rs12979860 and the homologous region of IL-28A are present, no off-target amplification was observed. This SNP genotyping assay is therefore specific for rs12979860 and all previously reported results are valid. Finally, using a completely synthetic in vitro competition assay it was possible to calculate the amount of off-target template that will produce 1/2 the maximum on-target (VIC) fluorescent signal, a value that is between a C/C genotype and a T/T genotype. This value is defined in the manuscript as the half maximum positive value, KHPV, and in the present assay KHPV is 15.75±0.0721, represented as the relative fold increase in the amount of IL-28A over rs12979860. This method will be of interest to those performing genotyping on highly conserved gene families.
Copyright © 2014 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HCV; IL-28B/IFNλ3; Off-target amplification; QRT-PCR; SNP genotyping; rs12979860

Mesh:

Substances:

Year:  2014        PMID: 24681052     DOI: 10.1016/j.jviromet.2014.03.016

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  1 in total

1.  IL-28B is a key regulator of B- and T-cell vaccine responses against influenza.

Authors:  Adrian Egli; Deanna M Santer; Daire O'Shea; Khaled Barakat; Mohammedyaseen Syedbasha; Madeleine Vollmer; Aliyah Baluch; Rakesh Bhat; Jody Groenendyk; Michael A Joyce; Luiz F Lisboa; Brad S Thomas; Manuel Battegay; Nina Khanna; Thomas Mueller; D Lorne J Tyrrell; Michael Houghton; Atul Humar; Deepali Kumar
Journal:  PLoS Pathog       Date:  2014-12-11       Impact factor: 6.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.